Showing results (121-130 of 198) with videos related to
Sort By:
Pageof 20
The Oncologist|September 1, 2020
Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-AnalysisMelissa G Lechner, Angeli C Bernardo, Alyssa Lampe, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|April 11, 2001
[Evaluation of a computer-assisted diagnosis system in breast carcinoma]M Funovics, S Schamp, T H Helbich, et al.Journal of Translational Medicine|June 11, 2011
Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell linesMelissa G Lechner, Carolina Megiel, Sarah M Russell, et al.AJR. American Journal of Roentgenology|January 1, 1997
Enhancement of hepatic parenchyma, aorta, and portal vein in helical CT: comparison of iodixanol and iopromideO Graf, G S Gazelle, S Kreuzer, et al.The Oncologist|November 9, 2025
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancerAlexis LeVee, Austin Kordic, Nora Ruel, et al.Thyroid : Official Journal of the American Thyroid Association|June 24, 2014
BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltrationTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.Radiology|June 27, 2001
Scaphoid fractures: evaluation with high-spatial-resolution US initial resultsA M Herneth, A Siegmeth, T R Bader, et al.JCEM Case Reports|June 11, 2026
Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1Alexandra Lim, Esther M Peluso, Ian A Downs, et al.JCEM Case Reports|February 18, 2025
Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the <i>RET</i> K666N Germline Pathogenic VariantAllison T Yip, Teresa H Kim, Esther M Peluso, et al.Journal of Immunological Methods|January 3, 2013
Generation of tumor-targeted antibody-CpG conjugatesZhongjun Li, Julie K Jang, Melissa G Lechner, et al.Pageof 20